Results 31 - 40 of 218 : Previous 1 2 3 4 5 6 7 8 9 Next
It's conquering the world, slowly but surely. But is it still a value play?
Extended Look at an Extended-Release Drug
The FDA is still investigating Teva's generic Wellbutrin XL.
Will Generic Biologics Get Special Treatment?
Looking at legislative efforts to boost the biotech industry.
Acupuncture beats Wyeth's Effexor in stopping hot flashes.
Ranbaxy's Troubles Won't Help Competitors
It may be hard to get a hit in with so much competition kicking Ranbaxy while it's down.
Teva and FDA's Never-Ending Court Battle
Teva looses latest battle against the FDA.
The generic-drug company decides to keep its specialty pharmaceutical subsidiary.
What's better than a high-quality stock? A high-quality stock with the wind at its back.
Tapping the Brakes on the Teva-Barr Deal
The FTC wants more information before it offers its approval.
Stock Advice That Will Change Your Life
Decide for yourself.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK